Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in gi...

por Leung, Ting Fan, Liu, Anthony Pak-Yin, Lim, Fong Seng, Thollot, Franck, Oh, Helen May Lin, Lee, Bee Wah, Rombo, Lars, Tan, Ngiap Chuan, Rouzier, Roman, Friel, Damien, De Muynck, Benoit, De Simoni, Stéphanie, Suryakiran, Pemmaraju, Hezareh, Marjan, Folschweiller, Nicolas, Thomas, Florence, Struyf, Frank
Publicado 2015

Randomized Open Trial Comparing 2-Dose Regimens of the Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Girls Aged 9–14 Years Versus a 3-Dose Regimen in Women Aged 15–25 Years...

por Puthanakit, Thanyawee, Huang, Li-Min, Chiu, Cheng-Hsun, Tang, Ren-Bin, Schwarz, Tino F., Esposito, Susanna, Frenette, Louise, Giaquinto, Carlo, McNeil, Shelly, Rheault, Paul, Durando, Paolo, Horn, Michael, Klar, Maximilian, Poncelet, Sylviane, De Simoni, Stéphanie, Friel, Damien, De Muynck, Benoit, Suryakiran, Pemmaraju V., Hezareh, Marjan, Descamps, Dominique, Thomas, Florence, Struyf, Frank
Publicado 2016

Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9–14 Years: A Randomized Trial

por Huang, Li-Min, Puthanakit, Thanyawee, Cheng-Hsun, Chiu, Ren-Bin, Tang, Schwarz, Tino, Pellegrino, Angelo, Esposito, Susanna, Frenette, Louise, McNeil, Shelly, Durando, Paolo, Rheault, Paul, Giaquinto, Carlo, Horn, Michael, Petry, Karl Ulrich, Peters, Klaus, Azhar, Toma, Hillemanns, Peter, De Simoni, Stephanie, Friel, Damien, Pemmaraju, Suryakiran, Hezareh, Marjan, Thomas, Florence, Descamps, Dominique, Folschweiller, Nicolas, Struyf, Frank
Publicado 2017